⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
accessnewswire.com
LEXX
LLY
19th Annual Morgan & Morgan Walk for Wishes® Raises Over $583,000 to Grant Life-Changing Wishes
globenewswire.com
GOOG
META
LLY
Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll
accessnewswire.com
NVO
LLY
RO LAUNCHES ELI LILLY'S KWIKPEN®, OFFERING PATIENTS A MORE CONVENIENT WAY TO TAKE ZEPBOUND®
prnewswire.com
LLY
La FDA aprueba Foundayo™ (orforglipron) de Lilly, la única pastilla GLP-1 para la pérdida de peso que puede tomarse a cualquier hora del día sin restricciones de comida o agua USA - español USA - English
prnewswire.com
LLY
Radioligand Therapy Market Expected to Surge to $10.72 Billion by 2030: Upsurge in Cancer Cases Fuelling Industry Growth at 10% CAGR
globenewswire.com
NVS
LLY
Adrenocortical Carcinoma Market Report 2026: Innovative Therapies Set to Transform the $4 Billion Adrenocortical Carcinoma Landscape
globenewswire.com
MRK
AZN
LLY
SNY
Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments
prnewswire.com
ABBV
LLY
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association's 2026 Scientific Sessions
prnewswire.com
LLY
NVO
DIA's LIFT Series Brings Startup Pitch Competitions, Innovation Programming to Global Annual Meeting
prnewswire.com
LLY
ABBV
MRNA